Helius Medical Tech Jumps on Funding to Launch Solana Treasury
By Kelly Cloonan
Shares of Helius Medical Tech surged after the company said it has launched an offering set to raise over $500 million in cash funding to kickstart its cryptocurrency-treasury strategy.
The stock more than doubled, to $20.00, midday Monday. Shares are down 96% this year.
The company said Monday the offering consists of proceeds from a private investment in a public equity transaction for the sale of its common stock at a purchase price of about $6.88.
It also includes an additional $750 million in stapled warrants to purchase shares of common stock, which would be exercisable for three years from the date of issuance, the company said.
The offering is led by Pantera Capital and Summer Capital, with participation from investors including Big Brain Holdings, Avenir, SinoHope, FalconX and others.
It is expected to close on Sept. 18.
The Newtown, Pa., company intends to use the proceeds from the offering to implement a digital asset treasury strategy and acquire SOL, the native cryptocurrency of the Solana blockchain.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
September 15, 2025 12:42 ET (16:42 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner
The Thrilling 37
Christine Benz: Why I Hired a Financial Planner
United States